Haloperidol plasma levels and clinical response: basic concepts and clinical data
Davis, J.M.; Ericksen, S.E.; Hurt, S.; Chang, S.S.; Javaid, J.I.; Dekirmenjian, H.; Casper, R.
Psychopharmacology Bulletin 21(1): 48-51
1985
ISSN/ISBN: 0048-5764 PMID: 3983337 Document Number: 261330
Document emailed within 1 workday
Related Documents
van Putten, T.; May, P.R.; Jenden, D.J. 1981: Plasma levels of chlorpromazine and clinical response Psychopharmacology Bulletin 17(1): 113-115Mavissakalian, M.R.; Jones, B.; Olson, S.; Perel, J.M. 1990: Clomipramine in obsessive-compulsive disorder: clinical response and plasma levels Journal of Clinical Psychopharmacology 10(4): 261-268
Montgomery, S.A.; Montgomery, D.B.; McAuley, R.; Rani, S.J. 1978: Mianserin plasma levels and differential clinical response in endogenous and reactive depression Acta Psychiatrica Belgica 78(5): 798-812
Stern, R.S.; Cobb, J.P.; Marks, I.M.; Jones, R.B.; Luscombe, D.K. 1977: A preliminary report on clinical response and plasma levels of clomipramine and desmethylclomipramine in obsessive-compulsive neurosis Postgraduate Medical Journal 53 Suppl. 4: 97-103
Merloz, P.; Huberson, C. 2002: Concepts de base pour la chirurgie orthopédique assistée par ordinateur : Concepts de base - Basic concepts in computer assisted orthopaedic surgery : Basic concepts Cahiers d'Enseignement de la Sofcot 80: 1-10
Van Putten, T.; Marder, S.R.; Mintz, J. 1991: Serum prolactin as a correlate of clinical response to haloperidol Journal of Clinical Psychopharmacology 11(6): 357-361
Volavka, J.; Cooper, T.B. 1987: Review of haloperidol blood level and clinical response: looking through the window Journal of Clinical Psychopharmacology 7(1): 25-30
1987: Calcium-entry blockage: basic concepts and clinical implications Circulation 75(6 Pt 2): V1-162
Ribeiro, M.P.; Brum, J.M.; Ferrario, C.M. 1992: A spectral analysis of the heart rate. the basic concepts and their clinical application Arquivos Brasileiros de Cardiologia 59(2): 141-149
Bigelow, L.B.; Kirch, D.G.; Braun, T.; Korpi, E.R.; Wagner, R.L.; Zalcman, S.; Wyatt, R.J. 1985: Absence of relationship of serum haloperidol concentration and clinical response in chronic schizophrenia: a fixed-dose study Psychopharmacology Bulletin 21(1): 66-68
Potkin, S.G.; Shen, Y.C.; Zhou, D.F.; Pardes, H.; Shu, L.; Phelps, B.; Poland, R. 1985: Does a therapeutic window for plasma haloperidol exist?: Preliminary Chinese data Psychopharmacology Bulletin 21(1): 59-61
Tandon, R.; Milner, K.; Jibson, M.D. 1999: Antipsychotics from theory to practice: integrating clinical and basic data Journal of Clinical Psychiatry 60(Suppl): 21-28
Altamura, A.C.; Buccio, M.; Colacurcio, F.; Colombo, G.; Terzi, A. 1986: Orphenadrine plasma levels and amelioration of extrapyramidal side effects in schizophrenic patients treated with haloperidol Acta Neurologica 8(1): 19-26
Nagao, M.; Kanamori, M.; Takatori, T.; Terazawa, K.; Gotouda, H. 1987: An attempt on removal of haloperidol in plasma by use of anti-haloperidol immunoadsorbent Nihon Hoigaku Zasshi 41(3): 232-235
Leff, J.P.; Tress, K.H. 1986: The response of untreated chronic schizophrenics to haloperidol and haloperidol decanoate International Clinical Psychopharmacology 1(Suppl 1): 27-40
Chong, S.A.; Remington, G. 1999: Plasma olanzapine and clinical response Journal of Clinical Psychopharmacology 19(2): 192-194
Wenting-Van Wijk, M.J.; Blankenstein, M.A.; Lafeber, F.P.; Bijlsma, J.W. 1999: Relation of plasma dexamethasone to clinical response Clinical and Experimental Rheumatology 17(3): 305-312
Yesavage, J.A. 1986: Psychotropic blood levels: a guide to clinical response Journal of Clinical Psychiatry 47 Suppl: 16-19
Estevez, F.; Amaro, G.; Giusti, M.; Lasalvia, L.; Havranek, H. 1993: Diclofenac vs nimesulide in arthrosis. Plasma levels and clinical efficacy Medicina 53(4): 307-314
Previato, G.; Loschiavo, C.; Lupo, A.; Faraggiana, T.; Valvo, E.; Tessitore, N.; Oldrizzi, L.; Maschio, G. 1981: Clinical significance of plasma factor VIIi levels in renal disease Clinical Nephrology 16(4): 200-206